{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:03:46Z","timestamp":1760889826089},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"10","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2019,10,24]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Prostate cancer is one of the most frequent types of cancer. Despite the existence of various treatment strategies, treatment of prostate cancer still presents serious difficulties (especially in advanced stages). Polyphenols have been extensively assessed in terms of their potential use for prostate cancer treatment and prevention. Catechins are among the most well-known polyphenols in this respect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>In this review, we summarize clinical study results concerning catechin applications with regard to prostate cancer treatment and prevention. We discuss some of the main mechanisms of the anticarcinogenic action of catechins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The main mechanisms of the anticarcinogenic action of catechins are subdivided into two major types: (i) direct action on cancer cells and (ii) indirect effect based on catechins\u2019s impact on the microenvironment of cancer cells, particularly in relation to the immune system. At this level catechins might reduce tumor-associated inflammation and immune tolerance.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871520619666190404153058","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T09:41:52Z","timestamp":1554802912000},"page":"1223-1231","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Possibility of Preventive and Therapeutic Use of Green Tea Catechins in Prostate Cancer"],"prefix":"10.2174","volume":"19","author":[{"given":"Vladimir S.","family":"Rogovskii","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology and Radiobiology, Pirogov Russian National Research Medical University (RNRMU), Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey V.","family":"Popov","sequence":"additional","affiliation":[{"name":"Department of General medical practice, Medical Institute Peoples' Friendship University of Russia, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai V.","family":"Sturov","sequence":"additional","affiliation":[{"name":"Department of General medical practice, Medical Institute Peoples' Friendship University of Russia, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai L.","family":"Shimanovskii","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Radiobiology, Pirogov Russian National Research Medical University (RNRMU), Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1074\/jbc.M004209200","volume":"276","author":"Nam S.","year":"2001","unstructured":"Nam S.; Smith D.M.; Dou Q.P.; Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001,276(16),13322-13330","journal-title":"J Biol Chem"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.11550","volume":"108","author":"Jian L.","year":"2004","unstructured":"Jian L.; Xie L.P.; Lee A.H.; Binns C.W.; Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004,108(1),130-135","journal-title":"Int J Cancer"},{"key":"ref=3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7432797","volume":"2016","author":"Hussain T.","year":"2016","unstructured":"Hussain T.; Tan B.; Yin Y.; Blachier F.; Tossou M.C.; Rahu N.; Oxidative stress and inflammation: What polyphenols can do for us? Oxid Med Cell Longev 2016,2016","journal-title":"Oxid Med Cell Longev"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2174\/1871520616666151116124549","volume":"16","author":"Kiemlian Kwee J.","year":"2016","unstructured":"Kiemlian Kwee J.; Yin and Yang of polyphenols in cancer prevention: A short review. Anticancer Agents Med Chem 2016,16(7),832-840","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=5","first-page":"24","volume":"79","author":"Fedotcheva T.A.","year":"2016","unstructured":"Fedotcheva T.A.; Matyushin A.I.; Rzheznikov V.M.; Shimanovskii N.L.; Antioxidant and cytoprotector properties of genistein - Isoflavone with estrogenic activity. Eksp Klin Farmakol 2016,79(12),24-28","journal-title":"Eksp Klin Farmakol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0094-0143(02)00016-2","volume":"29","author":"Gupta S.","year":"2002","unstructured":"Gupta S.; Mukhtar H.; Green tea and prostate cancer. Urol Clin North Am 2002,29(1),49-57","journal-title":"Urol Clin North Am"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phymed.2009.09.011","volume":"17","author":"Johnson J.J.","year":"2010","unstructured":"Johnson J.J.; Bailey H.H.; Mukhtar H.; Green tea polyphenols for prostate cancer chemoprevention: A translational perspective. Phytomedicine 2010,17(1),3-13","journal-title":"Phytomedicine"},{"key":"ref=8","author":"Jowko E.","year":"2015","unstructured":"Jowko E.; In: Antioxidants in Sport Nutrition 2015","journal-title":"In: Antioxidants in Sport Nutrition"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","volume":"66","author":"Bettuzzi S.","year":"2006","unstructured":"Bettuzzi S.; Brausi M.; Rizzi F.; Castagnetti G.; Peracchia G.; Corti A.; Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res 2006,66(2),1234-1240","journal-title":"Cancer Res"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"36674","DOI":"10.18632\/oncotarget.16230","volume":"8","author":"Cui K.","year":"2017","unstructured":"Cui K.; Li X.; Du Y.; Tang X.; Arai S.; Geng Y.; Xi Y.; Xu H.; Zhou Y.; Ma W.; Zhang T.; Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): A systematic review and adjusted indirect treatment comparison. Oncotarget 2017,8(22),36674-36684","journal-title":"Oncotarget"},{"key":"ref=11","first-page":"42","volume":"4","author":"Popov S.V.","year":"2008","unstructured":"Popov S.V.; Prophylactic use of the drug Indigal in diseases of the prostate. Effect Pharmacother Urol Nephrol 2008,4,42-44","journal-title":"Effect Pharmacother Urol Nephrol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/cncr.11200","volume":"97","author":"Jatoi A.","year":"2003","unstructured":"Jatoi A.; Ellison N.; Burch P.A.; Sloan J.A.; Dakhil S.R.; Novotny P.; Tan W.; Fitch T.R.; Rowland K.M.; Young C.Y.; Flynn P.J.; A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003,97(6),1442-1446","journal-title":"Cancer"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urolonc.2004.10.008","volume":"23","author":"Choan E.","year":"2005","unstructured":"Choan E.; Segal R.; Jonker D.; Malone S.; Reaume N.; Eapen L.; Gallant V.; A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary\/ alternative therapy approach. Urol Oncol 2005,23(2),108-113","journal-title":"Urol Oncol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/1940-6207.CAPR-08-0167","volume":"2","author":"McLarty J.","year":"2009","unstructured":"McLarty J.; Bigelow R.L.; Smith M.; Elmajian D.; Ankem M.; Cardelli J.A.; Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2009,2(7),673-682","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1940-6207.CAPR-11-0306","volume":"5","author":"Nguyen M.M.","year":"2012","unstructured":"Nguyen M.M.; Ahmann F.R.; Nagle R.B.; Hsu C.H.; Tangrea J.A.; Parnes H.L.; Sokoloff M.H.; Gretzer M.B.; Chow H.H.; Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: Evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) 2012,5(2),290-298","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-2000-8599","volume":"66","author":"Zhu M.","year":"2000","unstructured":"Zhu M.; Chen Y.; Li R.C.; Oral absorption and bioavailability of tea catechins. Planta Med 2000,66(5),444-447","journal-title":"Planta Med"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/pcan.2014.6","volume":"17","author":"Thomas R.","year":"2014","unstructured":"Thomas R.; Williams M.; Sharma H.; Chaudry A.; Bellamy P.; A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis 2014,17(2),180-186","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/1940-6207.CAPR-14-0324","volume":"8","author":"Kumar N.B.","year":"2015","unstructured":"Kumar N.B.; Pow-Sang J.; Egan K.M.; Spiess P.E.; Dickinson S.; Salup R.; Helal M.; McLarty J.; Williams C.R.; Schreiber F.; Parnes H.L.; Sebti S.; Kazi A.; Kang L.; Quinn G.; Smith T.; Yue B.; Diaz K.; Chornokur G.; Crocker T.; Schell M.J.; Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev Res (Phila) 2015,8(10),879-887","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=19","volume":"96","author":"Guo Y.","year":"2017","unstructured":"Guo Y.; Zhi F.; Chen P.; Zhao K.; Xiang H.; Mao Q.; Wang X.; Zhang X.; Green tea and the risk of prostate cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2017,96(13)","journal-title":"Medicine (Baltimore)"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.taap.2017.05.016","volume":"329","author":"Fechtner S.","year":"2017","unstructured":"Fechtner S.; Singh A.; Chourasia M.; Ahmed S.; Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1beta signaling in rheumatoid arthritis synovial fibroblasts. Toxicol Appl Pharmacol 2017,329,112-120","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=21","first-page":"6","author":"Sandhu J.","year":"2017","unstructured":"Sandhu J.; Tu H.Y.V.; Recent advances in managing chronic prostatitis\/chronic pelvic pain syndrome. F1000 Res 2017,6","journal-title":"F1000 Res"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10156-010-0098-9","volume":"17","author":"Yoon B.I.","year":"2011","unstructured":"Yoon B.I.; Ha U.S.; Sohn D.W.; Lee S.J.; Kim H.W.; Han C.H.; Lee C.B.; Cho Y.H.; Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model. J Infect Chemother 2011,17(2),189-194","journal-title":"J Infect Chemother"},{"key":"ref=23","volume":"6","author":"Naponelli V.","year":"2017","unstructured":"Naponelli V.; Ramazzina I.; Lenzi C.; Bettuzzi S.; Rizzi F.; Green tea catechins for prostate cancer prevention: Present achievements and future challenges. Antioxidants (Basel) 2017,6(2)","journal-title":"Antioxidants (Basel)"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"2417S","DOI":"10.1093\/jn\/133.7.2417S","volume":"133","author":"Adhami V.M.","year":"2003","unstructured":"Adhami V.M.; Ahmad N.; Mukhtar H.; Molecular targets for green tea in prostate cancer prevention. J Nutr 2003,133(7)(Suppl.),2417S-2424S","journal-title":"J Nutr"},{"key":"ref=25","first-page":"1907","volume":"11","author":"Tsai Y.J.","year":"2016","unstructured":"Tsai Y.J.; Chen B.H.; Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3. Int J Nanomedicine 2016,11,1907-1926","journal-title":"Int J Nanomedicine"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","volume":"15","author":"Malumbres M.","year":"2014","unstructured":"Malumbres M.; Cyclin-dependent kinases. Genome Biol 2014,15(6),122","journal-title":"Genome Biol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/carcin\/bgh235","volume":"25","author":"Caporali A.","year":"2004","unstructured":"Caporali A.; Davalli P.; Astancolle S.; D\u2019Arca D.; Brausi M.; Bettuzzi S.; Corti A.; The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 2004,25(11),2217-2224","journal-title":"Carcinogenesis"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(09)05001-5","volume":"105","author":"Rizzi F.","year":"2009","unstructured":"Rizzi F.; Bettuzzi S.; Clusterin (CLU) and prostate cancer. Adv Cancer Res 2009,105,1-19","journal-title":"Adv Cancer Res"},{"key":"ref=29","first-page":"405","volume":"17","author":"Giudice A.","year":"2017","unstructured":"Giudice A.; Montella M.; Boccellino M.; Crispo A.; D\u2019Arena G.; Bimonte S.; Facchini G.; Ciliberto G.; Botti G.; Quagliuolo L.; Caraglia M.; Capunzo M.; Epigenetic changes induced by green tea catechins are associated with prostate cancer. Curr Mol Med 2017,17(6),405-420","journal-title":"Curr Mol Med"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/epi.14.34","volume":"6","author":"Ngollo M.","year":"2014","unstructured":"Ngollo M.; Dagdemir A.; Karsli-Ceppioglu S.; Judes G.; Pajon A.; Penault-Llorca F.; Boiteux J.P.; Bignon Y.J.; Guy L.; Bernard-Gallon D.J.; Epigenetic modifications in prostate cancer. Epigenomics 2014,6(4),415-426","journal-title":"Epigenomics"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.04.009","volume":"166","author":"Massie C.E.","year":"2017","unstructured":"Massie C.E.; Mills I.G.; Lynch A.G.; The importance of DNA methylation in prostate cancer development. J Steroid Biochem Mol Biol 2017,166,1-15","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3390\/ijms16023350","volume":"16","author":"Lall R.K.","year":"2015","unstructured":"Lall R.K.; Syed D.N.; Adhami V.M.; Khan M.I.; Mukhtar H.; Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci 2015,16(2),3350-3376","journal-title":"Int J Mol Sci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms16022472","volume":"16","author":"Ng J.M.","year":"2015","unstructured":"Ng J.M.; Yu J.; Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci 2015,16(2),2472-2496","journal-title":"Int J Mol Sci"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bcp.2012.09.027","volume":"85","author":"Khan N.","year":"2013","unstructured":"Khan N.; Mukhtar H.; Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem Pharmacol 2013,85(5),667-672","journal-title":"Biochem Pharmacol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.24988","volume":"126","author":"Pandey M.","year":"2010","unstructured":"Pandey M.; Shukla S.; Gupta S.; Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer 2010,126(11),2520-2533","journal-title":"Int J Cancer"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mc.21939","volume":"53","author":"Kanwal R.","year":"2014","unstructured":"Kanwal R.; Pandey M.; Bhaskaran N.; Maclennan G.T.; Fu P.; Ponsky L.E.; Gupta S.; Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog 2014,53(1),8-18","journal-title":"Mol Carcinog"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.MP.0000071842.83169.5A","volume":"16","author":"Huang J.","year":"2003","unstructured":"Huang J.; Tan P.H.; Thiyagarajan J.; Bay B.H.; Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 2003,16(6),558-565","journal-title":"Mod Pathol"},{"key":"ref=38","volume":"8","author":"Xiang L.P.","year":"2016","unstructured":"Xiang L.P.; Wang A.; Ye J.H.; Zheng X.Q.; Polito C.A.; Lu J.L.; Li Q.S.; Liang Y.R.; Suppressive effects of tea catechins on breast cancer. Nutrients 2016,8(8)","journal-title":"Nutrients"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000375503","volume":"95","author":"Yiannakopoulou E.C.","year":"2015","unstructured":"Yiannakopoulou E.C.; Targeting DNA methylation with green tea catechins. Pharmacology 2015,95(3-4),111-116","journal-title":"Pharmacology"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568009617666170109110816","volume":"17","author":"Rogovskii V.S.","year":"2017","unstructured":"Rogovskii V.S.; The linkage between inflammation and immune tolerance: Interfering with inflammation in cancer. Curr Cancer Drug Targets 2017,17(4),325-332","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1038\/s41388-018-0318-9","volume":"37","author":"Garg R.","year":"2018","unstructured":"Garg R.; Blando J.M.; Perez C.J.; Lal P.; Feldman M.D.; Smyth E.M.; Ricciotti E.; Grosser T.; Benavides F.; Kazanietz M.G.; COX-2 mediates pro-tumorigenic effects of PKCepsilon in prostate cancer. Oncogene 2018,37(34),4735-4749","journal-title":"Oncogene"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1207\/S15327914NC4601_13","volume":"46","author":"Seeram N.P.","year":"2003","unstructured":"Seeram N.P.; Zhang Y.; Nair M.G.; Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr Cancer 2003,46(1),101-106","journal-title":"Nutr Cancer"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00432-018-2696-3","volume":"144","author":"Ciccarelli C.","year":"2018","unstructured":"Ciccarelli C.; Di Rocco A.; Gravina G.L.; Mauro A.; Festuccia C.; Del Fattore A.; Berardinelli P.; De Felice F.; Musio D.; Bouche M.; Tombolini V.; Zani B.M.; Marampon F.; Disruption of MEK\/ERK\/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo. J Cancer Res Clin Oncol 2018,144(9),1685-1699","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=44","first-page":"3054","volume":"8","author":"Wang M.","year":"2015","unstructured":"Wang M.; Lei Y.X.; Effects of tea polyphenols on proliferation and apoptosis of cadmium-transformed cells. Int J Clin Exp Med 2015,8(2),3054-3062","journal-title":"Int J Clin Exp Med"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-12-802215-3.00010-0","volume":"36","author":"Yang C.S.","year":"2014","unstructured":"Yang C.S.; Wang H.; Chen J.X.; Zhang J.; Effects of tea catechins on cancer signaling pathways. Enzymes 2014,36,195-221","journal-title":"Enzymes"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.phrs.2010.07.010","volume":"62","author":"Larsen C.A.","year":"2010","unstructured":"Larsen C.A.; Dashwood R.H.; Bisson W.H.; Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance. Pharmacol Res 2010,62(6),457-464","journal-title":"Pharmacol Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1055-9965.EPI-06-0892","volume":"16","author":"Li M.","year":"2007","unstructured":"Li M.; He Z.; Ermakova S.; Zheng D.; Tang F.; Cho Y.Y.; Zhu F.; Ma W.Y.; Sham Y.; Rogozin E.A.; Bode A.M.; Cao Y.; Dong Z.; Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev 2007,16(3),598-605","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/nu2121231","volume":"2","author":"Tsao R.","year":"2010","unstructured":"Tsao R.; Chemistry and biochemistry of dietary polyphenols. Nutrients 2010,2(12),1231-1246","journal-title":"Nutrients"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/156800911794519743","volume":"11","author":"Yang H.","year":"2011","unstructured":"Yang H.; Landis-Piwowar K.; Chan T.H.; Dou Q.P.; Green tea polyphenols as proteasome inhibitors: implication in chemoprevention. Curr Cancer Drug Targets 2011,11(3),296-306","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0006-2952(03)00585-9","volume":"66","author":"Wang X.","year":"2003","unstructured":"Wang X.; Song K.S.; Guo Q.X.; Tian W.X.; The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase. Biochem Pharmacol 2003,66(10),2039-2047","journal-title":"Biochem Pharmacol"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcp.2009.03.021","volume":"78","author":"Murase T.","year":"2009","unstructured":"Murase T.; Misawa K.; Haramizu S.; Hase T.; Catechin-induced activation of the LKB1\/AMP-activated protein kinase pathway. Biochem Pharmacol 2009,78(1),78-84","journal-title":"Biochem Pharmacol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","volume":"82","author":"Singh B.N.","year":"2011","unstructured":"Singh B.N.; Shankar S.; Srivastava R.K.; Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011,82(12),1807-1821","journal-title":"Biochem Pharmacol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10408398.2010.499808","volume":"52","author":"Le Bourvellec C.","year":"2012","unstructured":"Le Bourvellec C.; Renard C.M.; Interactions between polyphenols and macromolecules: Quantification methods and mechanisms. Crit Rev Food Sci Nutr 2012,52(3),213-248","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11094-016-1481-3","volume":"50","author":"Pozdeev A.O.","year":"2016","unstructured":"Pozdeev A.O.; Rasadkina E.N.; Burym A.A.; Knyazev V.V.; Koroteev M.P.; Matyushin A.I.; Koroteev A.M.; Semeikin A.V.; Shimanovskii N.L.; Synthesis and antiproliferative activity of new acylcatechins. Pharm Chem J 2016,50(8),523-525","journal-title":"Pharm Chem J"},{"key":"ref=55","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092284","volume":"23","author":"Shirakami Y.","year":"2018","unstructured":"Shirakami Y.; Shimizu M.; Possible mechanisms of green tea and its constituents against cancer. Molecules 2018,23(9)","journal-title":"Molecules"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.prnil.2016.05.002","volume":"4","author":"Oh B.","year":"2016","unstructured":"Oh B.; Figtree G.; Costa D.; Eade T.; Hruby G.; Lim S.; Elfiky A.; Martine N.; Rosenthal D.; Clarke S.; Back M.; Oxidative stress in prostate cancer patients: A systematic review of case control studies. Prostate Int 2016,4(3),71-87","journal-title":"Prostate Int"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.phymed.2011.06.006","volume":"18","author":"Ellinger S.","year":"2011","unstructured":"Ellinger S.; Muller N.; Stehle P.; Ulrich-Merzenich G.; Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies? Phytomedicine 2011,18(11),903-915","journal-title":"Phytomedicine"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.abb.2010.06.013","volume":"501","author":"Lambert J.D.","year":"2010","unstructured":"Lambert J.D.; Elias R.J.; The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention. Arch Biochem Biophys 2010,501(1),65-72","journal-title":"Arch Biochem Biophys"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1871520615666150824153523","volume":"16","author":"Candeias S.M.","year":"2016","unstructured":"Candeias S.M.; Gaipl U.S.; The immune system in cancer prevention, development and therapy. Anticancer Agents Med Chem 2016,16(1),101-107","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-017-0283-9","volume":"5","author":"Janssen L.M.E.","year":"2017","unstructured":"Janssen L.M.E.; Ramsay E.E.; Logsdon C.D.; Overwijk W.W.; The immune system in cancer metastasis: Friend or foe? J Immunother Cancer 2017,5(1),79","journal-title":"J Immunother Cancer"},{"key":"ref=61","first-page":"171","volume":"9","author":"Rogovskii V.S.","year":"2015","unstructured":"Rogovskii V.S.; Mechanisms of immune tolerance in cancer and in normality. Russ J Immunol 2015,9(18),171-185","journal-title":"Russ J Immunol"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.celrep.2018.06.081","volume":"24","author":"Graham D.B.","year":"2018","unstructured":"Graham D.B.; Jasso G.J.; Mok A.; Goel G.; Ng A.C.Y.; Kolde R.; Varma M.; Doench J.G.; Root D.E.; Clish C.B.; Carr S.A.; Xavier R.J.; Nitric Oxide engages an anti-inflammatory feedback loop mediated by peroxiredoxin 5 in phagocytes. Cell Rep 2018,24(4),838-850","journal-title":"Cell Rep"},{"key":"ref=63","first-page":"77","volume":"2","author":"Rogovskii V.S.","year":"2016","unstructured":"Rogovskii V.S.; Shimanovskii N.L.; Sergeeva E.G.; Immune mechanisms of and inflammatory reactions in cancer and their pharmacological regulation. Int Med J 2016,2,77-86","journal-title":"Int Med J"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.neo.2018.05.002","volume":"20","author":"Morgillo F.","year":"2018","unstructured":"Morgillo F.; Dallio M.; Della Corte C.M.; Gravina A.G.; Viscardi G.; Loguercio C.; Ciardiello F.; Federico A.; Carcinogenesis as a result of multiple inflammatory and oxidative hits: A comprehensive review from tumor microenvironment to gut microbiota. Neoplasia 2018,20(7),721-733","journal-title":"Neoplasia"},{"key":"ref=65","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.076.","author":"Kim H.J.","year":"2018","unstructured":"Kim H.J.; Lee S.Y.; Kim D.S.; Kang E.J.; Kim J.S.; Choi Y.J.; Oh S.C.; Seo J.H.; Kim J.S.; Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine- based palliative chemotherapy. Kor J Intern Med 2018","journal-title":"Kor J Intern Med"},{"key":"ref=66","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3140372","volume":"2016","author":"Karan D.","year":"2016","unstructured":"Karan D.; Dubey S.; From Inflammation to prostate cancer: The role of inflammasomes. Adv Urol 2016,2016","journal-title":"Adv Urol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bju.12153","volume":"112","author":"Yli-Hemminki T.H.","year":"2013","unstructured":"Yli-Hemminki T.H.; Laurila M.; Auvinen A.; Maattanen L.; Huhtala H.; Tammela T.L.; Kujala P.M.; Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum Prostate-Specific Antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int 2013,112(6),735-741","journal-title":"BJU Int"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","volume":"23","author":"Gurel B.","year":"2014","unstructured":"Gurel B.; Lucia M.S.; Thompson I.M.; Goodman P.J.; Tangen C.M.; Kristal A.R.; Parnes H.L.; Hoque A.; Lippman S.M.; Sutcliffe S.; Peskoe S.B.; Drake C.G.; Nelson W.G.; De Marzo A.M.; Platz E.A.; Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2014,23(5),847-856","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imr.2013.12.001","volume":"3","author":"Min K.J.","year":"2014","unstructured":"Min K.J.; Kwon T.K.; Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res 2014,3(1),16-24","journal-title":"Integr Med Res"},{"key":"ref=70","volume":"10","author":"Thomas S.","year":"2015","unstructured":"Thomas S.; Fisher K.H.; Snowden J.A.; Danson S.J.; Brown S.; Zeidler M.P.; Methotrexate is a JAK\/STAT pathway inhibitor. PLoS One 2015,10(7)","journal-title":"PLoS One"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"32024","DOI":"10.18632\/oncotarget.25882","volume":"9","author":"Sponaas A.M.","year":"2018","unstructured":"Sponaas A.M.; Yang R.; Rustad E.H.; Standal T.; Thoresen A.S.; Dao Vo C.; Waage A.; Slordahl T.S.; Borset M.; Sundan A.; PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients. Oncotarget 2018,9(62),32024-32035","journal-title":"Oncotarget"},{"key":"ref=72","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23082071","volume":"23","author":"Rawangkan A.","year":"2018","unstructured":"Rawangkan A.; Wongsirisin P.; Namiki K.; Iida K.; Kobayashi Y.; Shimizu Y.; Fujiki H.; Suganuma M.; Green Tea catechin is an alternative immune checkpoint inhibitor that inhibits pd-l1 expression and lung tumor growth. Molecules 2018,23(8)","journal-title":"Molecules"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ajpath.2018.02.014","volume":"188","author":"Haffner M.C.","year":"2018","unstructured":"Haffner M.C.; Guner G.; Taheri D.; Netto G.J.; Palsgrove D.N.; Zheng Q.; Guedes L.B.; Kim K.; Tsai H.; Esopi D.M.; Lotan T.L.; Sharma R.; Meeker A.K.; Chinnaiyan A.M.; Nelson W.G.; Yegnasubramanian S.; Luo J.; Mehra R.; Antonarakis E.S.; Drake C.G.; De Marzo A.M.; Comprehensive evaluation of programmed death-ligand 1 expression in primary and metastatic prostate cancer. Am J Pathol 2018,188(6),1478-1485","journal-title":"Am J Pathol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","volume":"559","author":"Calcinotto A.","year":"2018","unstructured":"Calcinotto A.; Spataro C.; Zagato E.; Di Mitri D.; Gil V.; Crespo M.; De Bernardis G.; Losa M.; Mirenda M.; Pasquini E.; Rinaldi A.; Sumanasuriya S.; Lambros M.B.; Neeb A.; Luciano R.; Bravi C.A.; Nava-Rodrigues D.; Dolling D.; Prayer-Galetti T.; Ferreira A.; Briganti A.; Esposito A.; Barry S.; Yuan W.; Sharp A.; de Bono J.; Alimonti A.; IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature 2018,559(7714),363-369","journal-title":"Nature"},{"key":"ref=75","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24443","volume":"2","author":"Santilli G.","year":"2013","unstructured":"Santilli G.; Anderson J.; Thrasher A.J.; Sala A.; Catechins and antitumor immunity: Not MDSC\u2019s cup of tea. OncoImmunology 2013,2(6)","journal-title":"OncoImmunology"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/acs.jafc.6b01115","volume":"64","author":"Kim Y.H.","year":"2016","unstructured":"Kim Y.H.; Won Y.S.; Yang X.; Kumazoe M.; Yamashita S.; Hara A.; Takagaki A.; Goto K.; Nanjo F.; Tachibana H.; Green tea catechin metabolites exert immunoregulatory effects on CD4(+) T Cell and natural killer cell activities. J Agric Food Chem 2016,64(18),3591-3597","journal-title":"J Agric Food Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","volume":"6","author":"Pasero C.","year":"2015","unstructured":"Pasero C.; Gravis G.; Granjeaud S.; Guerin M.; Thomassin-Piana J.; Rocchi P.; Salem N.; Walz J.; Moretta A.; Olive D.; Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer. Oncotarget 2015,6(16),14360-14373","journal-title":"Oncotarget"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2174\/092986708785132979","volume":"15","author":"Babu P.V.","year":"2008","unstructured":"Babu P.V.; Liu D.; Green tea catechins and cardiovascular health: An update. Curr Med Chem 2008,15(18),1840-1850","journal-title":"Curr Med Chem"},{"key":"ref=79","first-page":"203","volume":"220","author":"van het Hof K.H.","year":"1999","unstructured":"van het Hof K.H.; Wiseman S.A.; Yang C.S.; Tijburg L.B.; Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 1999,220(4),203-209","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3390\/ijms12095592","volume":"12","author":"Mereles D.","year":"2011","unstructured":"Mereles D.; Hunstein W.; Epigallocatechin-3-gallate (EGCG) for clinical trials: More pitfalls than promises? Int J Mol Sci 2011,12(9),5592-5603","journal-title":"Int J Mol Sci"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1940-6207.CAPR-09-0210","volume":"3","author":"Wang P.","year":"2010","unstructured":"Wang P.; Aronson W.J.; Huang M.; Zhang Y.; Lee R.P.; Heber D.; Henning S.M.; Green tea polyphenols and metabolites in prostatectomy tissue: Implications for cancer prevention. Cancer Prev Res (Phila) 2010,3(8),985-993","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/171294","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/171294\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/171294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T19:16:26Z","timestamp":1721157386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/171294\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520619666190404153058","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}